U.S. Auto Components Stock News

NasdaqGS:GT
NasdaqGS:GTAuto Components

Goodyear (GT) Stock Slips As Losses Persist Despite Margin Repair

Goodyear Tire & Rubber shares slipped 2.5% to US$6.77 today, which is a muted move given what the new numbers say about the core business. The headline is not a revenue surprise; it is the earnings grind. Goodyear is still posting quarterly losses, yet the Q2 loss per share narrowed compared with Q1 and segment operating income stayed in positive territory. For a stock that has already drifted lower over the past month, today’s reaction looks more like fatigue than panic. The real story sits...
NYSE:KRO
NYSE:KROChemicals

Kronos Worldwide (KRO) Stock Rebounds On Profit Return But Losses Linger

Kronos Worldwide stock rose 32.2% to about US$8.21 after its latest earnings, a sharp move for a pigment producer that had reported losses over the last year. The market responded to a return to profit in the quarter, with basic earnings per share of roughly US$0.13 and net income of US$15.2m. The short-term reaction is clear. The bigger question for you is whether this single profitable quarter marks the beginning of a recovery for a business that still shows trailing 12 month earnings in...
NYSE:RCUS
NYSE:RCUSBiotechs

Arcus Biosciences (RCUS) Stock Can Casdatifan Carry Mounting Losses

Arcus Biosciences came into this earnings print as a high expectation biotech story with a rich P/S multiple and a stock that had already climbed 11.7% over the past three months. The 2.3% pop to about US$28.35 after the Q2 release indicates that investors liked what they saw on the surface, but the real headline is different. Revenue reached US$41m while the company still reported a sizeable US$91m net loss. For a drug developer built on future cash flows, that mix of growing top line and...
NasdaqGS:WMG
NasdaqGS:WMGEntertainment

Warner Music Group (WMG) Stock Rises As Margins Reset The Debate

Warner Music Group stock has been stuck in reverse for months, yet the latest earnings forced the market to pause that downtrend. Shares ticked up 1.8% to US$26.46 after the Q3 release, even though the stock is still down about 21% over the past three months. That small bounce sits on top of a very different story in the numbers. The real headline is margin power. Revenue reached US$1,864m for the quarter while net income came in at US$204m, and trailing net margin now stands at 9.2%. For a...
NYSE:WES
NYSE:WESOil and Gas

Western Midstream Partners (WES) Stock Faces Margin Squeeze Despite Guidance Lift

Western Midstream Partners has spent the past year wearing the label of an income heavy midstream play with a valuation gap and margin questions. Today the stock inched up about 2% after earnings, a muted move considering the headline numbers. Revenue reached about US$1.22b for the quarter and basic earnings per unit landed just under US$1, both solid figures for a pipeline and gathering business where cash flow consistency matters. The real story for you as an investor is the expectation...
NYSE:ITT
NYSE:ITTMachinery

ITT (ITT) Following Earnings And 2026 Outlook, Is The Valuation Case Still Intact?

ITT (ITT) just delivered a busy August 6 update, pairing second quarter earnings and six month results with a fresh full year earnings outlook and a reaffirmed quarterly dividend for shareholders. See our latest analysis for ITT. ITT’s recent earnings, dividend affirmation and updated 2026 guidance have come alongside strong share price momentum, with a 30 day share price return of 16.14% and a year to date share price return of 23.08%. This has contributed to a 1 year total shareholder...
NYSE:GPGI
NYSE:GPGITech

GPGI (GPGI) Faces Lawsuit Fallout, Is The Stock Still A Bargain?

GPGI (GPGI) is back in focus after its latest earnings report and ongoing legal scrutiny tied to the Husky Technologies acquisition. Recent Q2 results and multiple class action lawsuits are now shaping how investors view the stock. See our latest analysis for GPGI. At a latest share price of $14.98, GPGI has seen mixed momentum, with the share price up 7.93% over 90 days but down 19.76% year to date. The 3 year total shareholder return of 176.88% points to a much stronger longer term record...
NYSE:ASB
NYSE:ASBBanks

Associated Banc-Corp (ASB) Could Be 7% Undervalued On Strong Q2 Earnings And Dividends

Associated Banc-Corp (ASB) is back in focus after second quarter results showed higher net interest income and net income year over year, along with affirmed common and preferred dividends that keep income minded investors watching the stock closely. See our latest analysis for Associated Banc-Corp. At a share price of $31.16, Associated Banc-Corp has moved higher over the year, with a year to date share price return of 20.96% and a 1 year total shareholder return of 35.77%. This suggests...
NasdaqCM:BTDR
NasdaqCM:BTDRSoftware

Bitdeer (BTDR) Stock Looks Fairly Priced Despite Big AI Expansion Plans

Bitdeer Technologies Group stock has declined 18.7% over the past year, yet the latest valuation checks suggest it is roughly in line with where a typical market multiple screen might place it rather than standing out as an obvious bargain. Over the past 12 months, Bitdeer Technologies Group shares are down 18.7%, which means recent investors have faced a clear drag on returns even before thinking about valuation. The long term, multi billion dollar AI data center lease in Norway can support...
NYSE:RIG
NYSE:RIGEnergy Services

Transocean (RIG) Stock Still Looks Discounted Against Fair Value

Transocean stock has delivered a 74.9% return over the past year, yet the latest valuation checks suggest a more nuanced picture, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to upside while market based multiples look closer to fair value. A 74.9% one year return puts Transocean firmly on investors' radar and raises the question of how much of its recovery story is already reflected in the share price. New and extended offshore rig contracts that add about US$292...
NYSE:NSP
NYSE:NSPProfessional Services

Why Insperity (NSP) Is Down 5.1% After Narrow 2026 Profit Outlook And Buyback Completion - And What's Next

In the past quarter, Insperity, Inc. reported second‑quarter 2026 sales of US$1,686 million and net income of US$4 million, turning around from a net loss a year earlier, and issued guidance that ranges from a modest loss to a small profit for the third quarter and US$28 million to US$51 million in net income for full‑year 2026. Alongside completing a long‑running US$1.10 billion share repurchase program and filing an US$85.18 million ESOP‑related shelf registration, management highlighted...
NasdaqGS:MLYS
NasdaqGS:MLYSBiotechs

Why Mineralys Therapeutics (MLYS) Could Be 47% Undervalued Following Its Q2 Results Date

Mineralys Therapeutics (MLYS) has set August 11, 2026 as the date to report its second quarter results. The company will hold a conference call and webcast that may refocus attention on its cardiorenal drug pipeline. See our latest analysis for Mineralys Therapeutics. At a share price of $26.99, Mineralys Therapeutics has seen short term pressure, with the 30 day share price return down 11.39% and the year to date share price return down 24.42%. However, the 1 year total shareholder return of...
NYSE:WAL
NYSE:WALBanks

Western Alliance (WAL) Stock Could Still Be Discounted After A 73% Run

Western Alliance Bancorporation stock has delivered a 73.2% total return over the past three years, yet the current checks still suggest the shares lean cheap rather than fully priced in. With the company now emphasizing share buybacks alongside loan growth and deposit optimization, investors are weighing whether the recent performance already reflects these shifts or if there is still value on the table. A 73.2% return over three years marks a strong outcome for holders, which raises the...
NasdaqGS:CNXC
NasdaqGS:CNXCProfessional Services

Does Concentrix's iX AI Orchestration Focus at Ai4 2026 Reframe Its Platform Ambitions (CNXC)?

Concentrix Corporation recently participated in the Ai4 2026 conference at The Venetian in Las Vegas, where it delivered a panel discussion on “The Generative AI Playbook: Setting Your Enterprise Up for Success” and showcased its proprietary iX orchestration technology at booth #1562. The company’s decision to spotlight iX, which links people, AI, data, and workflows into a single connected operation, highlights how deeply AI is being woven into its enterprise solutions and client...
NasdaqGS:IBRX
NasdaqGS:IBRXBiotechs

ImmunityBio (IBRX) Stock May Trade At A Premium To Fair Value

ImmunityBio stock has delivered a very strong 321.9% gain over the past three years, yet the current checks on valuation and market pricing point to a company that does not clearly stand out as either a bargain or obviously overpriced. The 321.9% return over three years is very large, which makes today’s entry price more important for investors who are considering the next phase of the story. Recent approvals and regulatory progress for ANKTIVA can support confidence in ImmunityBio’s revenue...
NYSE:SMG
NYSE:SMGChemicals

Scotts Miracle Gro (SMG) Could Be 18% Undervalued As SMG 2.0 Takes Shape

Scotts Miracle-Gro (SMG) is drawing fresh attention after outlining its multi-year SMG 2.0 plan, along with updated earnings guidance, mid-term financial targets, and a recently affirmed cash dividend. See our latest analysis for Scotts Miracle-Gro. The share price reaction to Scotts Miracle-Gro's SMG 2.0 update and guidance has been negative in the very short term, with the 1 day share price return down 6.15% and the 7 day share price return down 9.15%. However, the 1 year total shareholder...
NYSE:TRV
NYSE:TRVInsurance

Does Travelers’ Synergy Rollout and Resilience Push Reframe Its Competitive Edge for Investors (TRV)?

Travelers Companies recently completed the nationwide rollout of Travelers Synergy, its product liability insurance for life sciences firms, by launching the offering in California, while also advancing its Travelers Across America preservation and community resilience campaign with the National Trust for Historic Preservation. This combination of a fully national, specialized life sciences product and a high-visibility community resilience initiative highlights how Travelers is pairing...
NYSE:CCS
NYSE:CCSConsumer Durables

Is Century Communities (CCS) Still Undervalued Following Its Strong 90 Day Run?

Century Communities (CCS) has been drawing attention after its stock showed strong price momentum in recent months. This performance is supported by a Momentum Score of B and a P/S ratio of 0.51, which keeps valuation in focus for investors. See our latest analysis for Century Communities. Over the past year, Century Communities has seen a 16.92% year to date share price return and a 16.55% one year total shareholder return, while its 25.27% 90 day share price return points to building...
NYSE:CNC
NYSE:CNCHealthcare

Centene (CNC) Stock May Be Cheap Following Raised 2026 Outlook

Centene stock has more than doubled over the past year, yet the valuation checks still lean on the cheap side, which raises a clear question about how much of the recent optimism is already in the price. Centene has returned 154.2% over the past year, which puts recent shareholders in a strong position and makes the current price level far more important for anyone considering new capital. Stronger profit and an improved outlook have supported sentiment, while slower than expected Medicaid...
NYSE:WAT
NYSE:WATLife Sciences

Waters (WAT) Is Up 5.1% After Raising 2026 Revenue Guidance Amid Integration Progress – What’s Changed

In early August 2026, Waters Corporation reported second-quarter results showing sales of US$1.65 billion versus US$771 million a year earlier, alongside a shift from net income of US$147 million to a net loss of US$136 million, and issued third-quarter and full-year 2026 revenue guidance of US$1.75–1.76 billion and US$6.42–6.48 billion respectively. Management highlighted 9% organic constant currency growth, strong performance in pharmaceutical and academic markets, faster growth in newly...
NYSE:BF.B
NYSE:BF.BBeverage

Is Brown Forman (BF.B) Fully Valued On The Failed Buyout Offer?

Buyout proposal falls through while dividends continue Sazerac Company cancelled its proposed US$32 per share, roughly US$15b cash acquisition of Brown-Forman (BF.B) on July 26, 2026, after Brown family interests deemed the offer misaligned with their long term vision. See our latest analysis for Brown-Forman. Brown-Forman shares now trade at US$28.38, with a 1 month share price return of 10.21% and year to date gain of 8.57%. However, the 1 year total shareholder return has declined 3.81%...
NasdaqGS:EBAY
NasdaqGS:EBAYMultiline Retail

Is eBay (EBAY) Cheap After Strong Earnings And Higher Guidance?

eBay (EBAY) is back in focus after reporting second quarter 2026 earnings that exceeded expectations, with revenue of US$3.13b and net income of US$550m. The company also lifted guidance despite earlier analyst concerns. See our latest analysis for eBay. Despite a 1 day share price gain of 1.41% to US$111.15 after the earnings beat and higher guidance, eBay’s 7 day and 30 day share price returns remain slightly negative. However, the 1 year total shareholder return of 21.65% and the very...
NasdaqGS:RIVN
NasdaqGS:RIVNAuto

Rivian’s Narrowing Losses And R2 Momentum Might Change The Case For Investing In Rivian Automotive (RIVN)

Rivian Automotive, Inc. reported second-quarter 2026 results showing sales of US$515 million and revenue of US$1.66 billion, with net loss narrowing to US$833 million and loss per share improving to US$0.63 compared with the prior year. Alongside these results, Rivian highlighted growing contributions from software and services, including its Volkswagen joint venture, and raised its 2026 vehicle delivery outlook on early momentum from the new R2 model. We’ll now examine how Rivian’s...
NasdaqGS:WDAY
NasdaqGS:WDAYSoftware

What Workday (WDAY)'s AI-Driven Software Sell-Off Means For Shareholders

Earlier this week, software stocks fell after quarterly earnings from Datadog, Figma, and HubSpot disappointed investors, dragging down peers including Workday amid sector-wide concern that AI could disrupt existing software business models. This reaction highlights how quickly sentiment can shift in the enterprise software sector when investors question whether incumbents are positioned to harness AI rather than be threatened by it. We’ll now examine how this sector-wide AI anxiety, and...